177 related articles for article (PubMed ID: 32280307)
1. The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors.
Tu C; Ren X; He J; Li S; Qi L; Duan Z; Wang W; Li Z
Cancer Cell Int; 2020; 20():115. PubMed ID: 32280307
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MIR31HG as a prognostic predictor for malignant cancers: A meta- and bioinformatics analysis.
Wei Y; Zhai Y; Liu X; Jin S; Zhang L; Wang C; Zou H; Hu J; Wang L; Jiang J; Shen X; Pang L
J Clin Lab Anal; 2022 Jan; 36(1):e24082. PubMed ID: 34837713
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis.
Zhang C; Ren X; He J; Wang W; Tu C; Li Z
Cancer Cell Int; 2019; 19():261. PubMed ID: 31632195
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
6. MIR31HG Expression Predicts Poor Prognosis and Promotes Colorectal Cancer Progression.
Wang J; Liu B; Cao J; Zhao L; Wang G
Cancer Manag Res; 2022; 14():1973-1986. PubMed ID: 35733512
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
[TBL] [Abstract][Full Text] [Related]
9. Significance of lncRNA
Zhou Y; Fan Y; Zhou X; Mou A; He Y; Wang F; Liu Y
Biomark Med; 2020 Mar; 14(4):303-316. PubMed ID: 32134327
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma.
Sun Y; Jia X; Wang M; Deng Y
Cancer Manag Res; 2019; 11():8055-8064. PubMed ID: 31564967
[TBL] [Abstract][Full Text] [Related]
11. MIR31HG promotes cell proliferation and invasion by activating the Wnt/β-catenin signaling pathway in non-small cell lung cancer.
Zheng S; Zhang X; Wang X; Li J
Oncol Lett; 2019 Jan; 17(1):221-229. PubMed ID: 30655759
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
Chen W; Wang F; Yu X; Qi J; Dong H; Cui B; Zhang Q; Wu Y; An J; Ni N; Liu C; Han Y; Zhang S; Schmitt CA; Deng J; Yu Y; Du J
Oncogene; 2024 May; 43(18):1328-1340. PubMed ID: 37950038
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression.
Wang R; Ma Z; Feng L; Yang Y; Tan C; Shi Q; Lian M; He S; Ma H; Fang J
Mol Cancer; 2018 Nov; 17(1):162. PubMed ID: 30458787
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of lncRNA MIR31HG in melanoma.
Xu HL; Tian FZ
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4389-4395. PubMed ID: 32373976
[TBL] [Abstract][Full Text] [Related]
16. Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer.
Nie FQ; Ma S; Xie M; Liu YW; De W; Liu XH
Tumour Biol; 2016 Jun; 37(6):7693-701. PubMed ID: 26692098
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MIR31HG is activated by SP1 and promotes cell migration and invasion by sponging miR-214 in NSCLC.
Dandan W; Jianliang C; Haiyan H; Hang M; Xuedong L
Gene; 2019 Apr; 692():223-230. PubMed ID: 30659947
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of lncRNA SNGH3 Predicts Unfavorable Prognosis and Clinical Outcomes in Human Cancers: Evidence from a Meta-Analysis.
Jiang Y; Le L
Biomed Res Int; 2020; 2020():7974034. PubMed ID: 32802874
[TBL] [Abstract][Full Text] [Related]
20. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
